Posts Tagged ‘mood booster’

Researchers confirm EPA is powerful natural antidepressant Takeomega3 750mg EPA

Tuesday, March 15th, 2011

Researchers from the University of Illinois at Chicago have confirmed that omega-3 fatty acids exhibit powerful antidepressant and brain boosting benefits that have not received the high level of attention they deserve. The team, led by Dr. John M. Davis, discovered that eicosapentenoic acid (EPA) and docosahexaenoic acid (DHA) — two types of omega-3 fatty acids recognized for their powerful nutritional benefits — are effective enough at improving mood that they may potentially eliminate the need for many people to take antidepressant drugs.

The researchers analyzed 15 randomized, double-blind, placebo-controlled studies about omega-3s and found that taking either EPA alone or EPA together with DHA helps to alleviate depression symptoms And since DHA alone did not exhibit antidepressant benefits, the team has identified EPA as the primary active compound in improving mental health.

“Our analysis clarifies the precise type of omega-3 fatty acid that is effective for people with depression and explains why previous findings have been contradictory,” explained Davis. “The EPA predominant formulation is necessary for the therapeutic action to occur.”

People who are deficient in omega-3s are more likely to experience depression than people have consume adequate amounts. Davis and his team found in a previous study that pregnant women deficient in omega-3s are more prone to depression during and after pregnancy than those who get enough of it.
Take Omega 3 has 750 mg of the key active omega3 EPA per capsule as a result it is a true one per day dose as its 85% concentrate. Consumers should be aware that just because a product states it 1000mg omega 3 it may infact have very low levels of omega 3

Treatment of depression with omega3 – encouraging results from largest clinical study

Monday, November 15th, 2010

The study was published in the online Journal of Clinical Psychiatry.This was the largest study ever conducted assessing Omega-3’s efficacy in treating major depression. It was carried out in conjunction with researchers from centres affiliated with the UdM’s Réseau universitaire intégré de santé (RUIS), from McGill University, Université Laval in Quebec City and Queen’s University in Kingston, Ontario. The study was supported by the European the Fondation du CHUM and the CRCHUM.

Initial analyses failed to clearly demonstrate the effectiveness of Omega-3 for all patients taking part in the study. Other analyses, however, revealed that Omega-3 improved depression symptoms in patients diagnosed with depression unaccompanied by an anxiety disorder. Efficacy for these patients was comparable to that generally observed with conventional antidepressant treatment.From October 2005 to January 2009, 432 male and female participants with major unipolar depression were recruited to take part in this randomized, double-blind study (neither patients nor researchers knew which capsules patients received). For eight weeks, half of the participants took three capsules per day of a fish oil supplement containing high concentrations of eicosapentaenoic acid (EPA). The other half took three identical capsules of a placebo consisting of sunflower oil, flavoured with a small quantity of fish oil. In contrast with typical clinical studies designed to assess the effectiveness of antidepressants, this study included a high proportion of patients with complex and difficult-to-treat conditions, including patients resistant to conventional antidepressant treatments and patients also suffering from an anxiety disorder. The aim was to assess the value of Omega-3 supplementation in a group of individuals more like those treated in outpatient clinics.Some 11% of men and 16% of women in Canada will suffer from major depression at some point in their lives, making this disorder one of our society’s leading public health issues. Depression, which is now the world’s fourth leading cause of morbidity and death is expected to move up to the number two position by 2020. “Despite significant progress in neuroscience over the past two decades, depression is difficult to treat,” Dr. Lespérance noted. In view of the large number of patients who stop taking their medications in the first few months of treatment and those who refuse such treatment due to fear of stigmatization or side effects, it comes as no surprise that a large number of patients suffering from major depression use alternative treatments offered outside the healthcare system. “Many of these treatments have not been adequately evaluated. That is why it was important to assess the efficacy of Omega-3, one of the most popular alternative approaches,” he added.It is important to note that the study assessed use of Omega-3 for eight weeks, at doses of 1050 mg of EPA and 150 mg of DHA each day. It is currently unknown whether taking higher doses or taking supplements over a longer period would yield different results.

Great Britain Flag
Made in the UK - Take Omega 3 Suspendisse lacinia ultricies justo, at ultricies nisi tempus ac. Cras sed vehicula metus. Phasellus...